These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 13641044)

  • 21. Effects of LSD-25 on brain serotonin.
    FREEDMAN DX
    J Pharmacol Exp Ther; 1961 Nov; 134():160-6. PubMed ID: 13894866
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of alkaloids of ololiuqui in man.
    Isbell H; Gorodetzky CW
    Psychopharmacologia; 1966; 8(5):331-9. PubMed ID: 5923939
    [No Abstract]   [Full Text] [Related]  

  • 23. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal learning enhanced by lysergic acid diethylamide (LSD): concomitant rise in brain 5-hydroxytryptamine levels.
    King AR; Martin IL; Melville KA
    Br J Pharmacol; 1974 Nov; 52(3):419-26. PubMed ID: 4458849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agonist-directed signaling of serotonin 5-HT2C receptors: differences between serotonin and lysergic acid diethylamide (LSD).
    Backstrom JR; Chang MS; Chu H; Niswender CM; Sanders-Bush E
    Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):77S-81S. PubMed ID: 10432492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of D-lysergic acid diethylamide (LSD-25) and 2-bromo-D-lysergic acid diethylamide (BOL-148) on sleeping behavior in rats].
    Loew DM; Depoortere H; Vigouret JM
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):394-5. PubMed ID: 4326420
    [No Abstract]   [Full Text] [Related]  

  • 27. (+)Lysergic acid diethylamide, but not its nonhallucinogenic congeners, is a potent serotonin 5HT1C receptor agonist.
    Burris KD; Breeding M; Sanders-Bush E
    J Pharmacol Exp Ther; 1991 Sep; 258(3):891-6. PubMed ID: 1679849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropharmacological reassessment of the discriminative stimulus properties of d-lysergic acid diethylamide (LSD).
    Cunningham KA; Appel JB
    Psychopharmacology (Berl); 1987; 91(1):67-73. PubMed ID: 3103161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of serotonin, d-lysergic acid diethylamide and 2-brom-LSD on the incorporation of [35S] methionine into brain proteins and on the level of ATP in the brain.
    KRAWCZYNSKI J
    J Neurochem; 1961 Apr; 7():1-4. PubMed ID: 13831062
    [No Abstract]   [Full Text] [Related]  

  • 30. Serotonin-sensitive adenylate cyclase in neural tissue and its similarity to the serotonin receptor: a possible site of action of lysergic acid diethylamide.
    Nathanson JA; Greengard P
    Proc Natl Acad Sci U S A; 1974 Mar; 71(3):797-801. PubMed ID: 4595572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LSD-25 and the status and level of brain serotonin.
    FREEDMAN DX; GIARMAN NJ
    Ann N Y Acad Sci; 1962 Jan; 96():98-107. PubMed ID: 13894865
    [No Abstract]   [Full Text] [Related]  

  • 32. Some CNS electrophysiologic effects of serotonin and lysergic acid diethylamide.
    GUNN CG
    Psychiatr Res Rep Am Psychiatr Assoc; 1960 Jan; 12():194-203. PubMed ID: 13851827
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of the chronic and acute effects of D-lysergic acid diethylamide (LSD) treatment on rat brain serotonin and norepinephrine.
    Peters DA
    Biochem Pharmacol; 1974 Jan; 23(2):231-7. PubMed ID: 4149793
    [No Abstract]   [Full Text] [Related]  

  • 34. 'Candyflipping': synergistic discriminative effect of LSD and MDMA.
    Schechter MD
    Eur J Pharmacol; 1998 Jan; 341(2-3):131-4. PubMed ID: 9543229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of LSD, BOL, and chlorpromazine on "neurohormone" metabolism.
    SIVA SANKAR DV; PHIPPS E; GOLD E; SANKAR DB
    Ann N Y Acad Sci; 1962 Jan; 96():93-7. PubMed ID: 13913509
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical studies with LSD-25 and two substances related to serotonin.
    KLEE GD; BERTINO J; CALLAWAY E; WEINTRAUB W
    J Ment Sci; 1960 Jan; 106():301-8. PubMed ID: 14409633
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of (+)-lysergic acid diethylamide and other drugs on the carotid sinus reflex.
    GINZEL KH
    Br J Pharmacol Chemother; 1958 Sep; 13(3):250-9. PubMed ID: 13584725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of the neurophysiological effects of lysergic acid diethylamide (LSD) and other phychotomimetic agents.
    EVARTS EV
    Ann N Y Acad Sci; 1957 Mar; 66(3):479-95. PubMed ID: 13425237
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug-induced alterations of the sub-cellular distribution of 5-hydroxytryptamine (serotonin) in rat's brain.
    GIARMAN NJ; SCHANBERG SM
    Biochem Pharmacol; 1962 Aug; 9():93-6. PubMed ID: 13947638
    [No Abstract]   [Full Text] [Related]  

  • 40. Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide.
    Andén NE; Corrodi H; Fuxe K; Hökfelt T
    Br J Pharmacol; 1968 Sep; 34(1):1-7. PubMed ID: 5302837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.